Cargando…
Neoadjuvant Immunotherapy in the Treatment of Renal Cell Carcinoma: A Case Series
Renal cell carcinoma is a type of urologic cancer that has a poor prognosis, with the majority of these being clear cell renal carcinoma. This subset has a tendency to cause disruptions in the cell cycle, making immune checkpoint inhibitors for adjuvant treatment of renal cell carcinoma the predomin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387746/ https://www.ncbi.nlm.nih.gov/pubmed/35989791 http://dx.doi.org/10.7759/cureus.27019 |